Stenting versus non-stenting following uncomplicated ureteroscopic lithotripsy: comparsion and evaluation of symptoms

Slaviša Č Savić; Vinka Vukotić; Miodrag Lazić; Nataša Savić

doi:10.2298/VSP150525071S

Slaviša Č Savić Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
Vinka Vukotić Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
Miodrag Lazić Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
Nataša Savić Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP150525071S

Keywords: ureteroscopy, lithotripsy, stents, lower urinary tract symptoms, comparative study,

Abstract

Background/Aim. Currently, ureterorenoscopic (URS) stone fragmentation and removal is the treatment of choice for managing ureteral stones, especially mid and distal ones and is advocated as initial management of ureteric stones. The aim of this work was to evaluate the symptoms, necessity, potential benefits and adverse effects of ureteral stent placement after uncomplicated ureteroscopic lithotripsy. Methods. This retrospective-prospective study evaluated a total of 125 patients who had underwent ureteroscopic lithotripsy (URSL). The patients were divided into two groups: stented (59 patients) and unstented (controls, 66 patients). The outcomes measured and compared between the two groups included: stone free rate, postoperative patient pain validated by scale, lower urinary tract symptoms (LUTS), the need for unplanned hospital care, stent related complications, and functional recovery in the form return to normal physical activities. Results. A successful outcome, defined as being stone-free after 12 weeks, was achieved in all 125 (100%) patients. The stone-free rate showed no significant differences between the two groups. LUTS was a frequent complaint in the stented group, with statistically significant difference in the domain of frequency/urgency (p = 0.0314). There was a statistically significant difference between the groups in the mean operative time and mean hospitalization time, mean pain visual analog scale (VAS) score and in the use of non-narcotic analgesic. On the day of the surgery and until postoperative day 3 (POD 3) and postoperative day 5 (POD 5), the pain score was much higher among stented patients than among the controls (p = 0.0001) and non-narcotic analgesic use (p = 0.001) was frequently required in the stented group. Conclusion. Routine placement of ureteral stent after URSL is not mandatory and may be associated with stent side effects. Uncomplicated URSL is safe without stent placement after the treatment.

Author Biographies

Slaviša Č Savić, Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia

Urology

Vinka Vukotić, Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia

Urology

Miodrag Lazić, Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia

Urology

Nataša Savić, Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia

Urology

References

Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol 1997; 158(5): 1915−21.

Saltzman B. Ureteral stents. Indications, variations and compli-cations. Urol Clin North Am 1988; 15(3): 481−91.

Aoyagi T, Hatano T, Tachibana M, Hata M. Short-term ureteral catheter stenting after uncomplicated transurethral uretero-lithotomy. World J Urol 2004; 22(6): 449−51.

Faqih SR, Shamsuddin AB, Chakrabarti A, Atassi R, Kardar AH, Osman MK, et al. Polyurethane internal ureteral stents in treat-ment of stone patients: morbidity related to indwelling times. J Urol 1991; 146(6): 1487−91.

Richter S, Ringel A, Shalev M, Nissenkorn I. The indwelling ureteric stent: a ‘friendly’ procedure with unfriendly high morbidity. Br J Urol 2000; 85(4): 408−11.

Denstedt JD, Wollin TA, Sofer M, Nott L, Weir M, D'A Honey RJ. A prospective randomized controlled trial comparing non-stented versus stented ureteroscopic lithotripsy. J Urol 2001; 165(5): 1419−22.

Wu C, Shee J, Lin W, Lin C, Chen C. Comparison between extracorporeal shock wave lithotripsy and semirigid ureterore-noscope with holmium:YAG laser lithotripsy for treating large proximal ureteral stones. J Urol 2004; 172(5 Pt 1): 1899−902.

Byrne RR, Auge BK, Kourambas J, Munver R, Delvecchio F, Preminger GM. Routine ureteral stenting is not necessary after ureteros-copy and ureteropyeloscopy: a randomized trial. J Endourol 2002; 16(1): 9−13.

Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX, Timoney AG, Barry MJ. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 2003; 169(3): 1065−9.

Duvdevani M, Chew BH, Denstedt JD. Minimizing symptoms in patients with ureteric stents. Curr Opin Urol 2006; 16(2): 77−82.

Ibrahim HM, Al-Kandari AM, Shaaban HS, Elshebini YH, Shokeir AA. Role of Ureteral Stenting After Uncomplicated Ureteros-copy for Distal Ureteral Stones: A Randomized, Controlled Trial. J Urol 2008; 180(3): 961−5.

Pollard SG, Macfarlane R. Symptoms arising from Double-J ure-teral stents. J Urol 1988; 139(1): 37−8.

Bregg K, Riehle RA. Morbidity associated with indwelling inter-nal ureteral stents after shock wave lithotripsy. J Urol 1989; 141(3): 510−2.

Kuyumcuoglu U, Eryildirim B, Tuncer M, Faydaci G, Tarhan F, Ozgül A. Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Can Urol Assoc J 2012; 6(6): E234−7.

Borboroglu PG, Amling CL, Schenkman NS, Monga M, Ward JF, Piper NY, et al. Ureteral stenting after ureteroscopy for distal ureteral calculi: a multi-institutional prospective randomized controlled study assessing pain, outcomes and complications. J Urol 2001; 166(5): 1651−7.

Leibovici D, Cooper A, Lindner A, Ostrowsky R, Kleinmann J, Veli-kanov S, et al. Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc J 2005; 7(8): 491−4.

Joshi HB, Newns N, Stainthorpe A, Macdonagh RP, Keeley FX, Ti-money AG. Ureteral Stent Symptom Questionnaire: Develop-ment and Validation of a Multidimensional Quality of Life Measure. J Urol 2003; 169(3): 1060−4.

Damiano R, Autorino R, Esposito C, Cantiello F, Sacco R, de Sio M, et al. Stent Positioning after Ureteroscopy for Urinary Calculi: The Question Is Still Open. Eur Urol 2004; 46(3): 381−8.

Keeley FX, Timoney AG. Routine stenting after ureteroscopy: think again. Eur Urol 2007; 52(3): 642−4.

Falahatkar S, Salehi M, Asgari SA, Sharifi SH, Akbarpour M, Khaledi F, et al. Is Ureteral Stenting Necessary After Uncom-plicated Ureteroscopy Lithotripsy for Small Middle and Distal Ureteral Stones. Urotoday Int J 2009; 2(5): doi:10.3834/uij.1944-5784.2009.10.12

Jeong H, Kwak C, Lee SE. Ureteric stenting after ureteroscopy for ureteric stones: a prospective randomized study assessing symptoms and complications. BJU Int 2004; 93(7): 1032−4.

Srivastava A, Gupta R, Kumar A, Kapoor R, Mandhani A. Routine stenting after ureteroscopy for distal ureteral calculi is unne-cessary: results of a randomized controlled trial. J Endourol 2003; 17(10): 871−4.